COVID-19 therapeutics: Small-molecule drug development targeting SARS-CoV-2 main protease

T Kronenberger, SA Laufer, T Pillaiyar - Drug Discovery Today, 2023 - Elsevier
The severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) is the causative factor
behind the 2019 global coronavirus pandemic (COVID-19). The main protease, known as M …
被引用次数：25 相关文章

COVID-19 therapeutics: Small-molecule drug development targeting SARS-CoV-2 main protease

T Kronenberger, S Laufer, T Pillaiyar - Drug Discovery Today, 2023 - europepmc.org
The severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) is the causative factor
behind the 2019 global coronavirus pandemic (COVID-19). The main protease, known as M …

COVID-19 therapeutics: small-molecule drug development targeting SARS-CoV-2 main protease

T Kronenberger, SA Laufer, T Pillaiyar - Drug discovery today - pubmed.ncbi.nlm.nih.gov
The severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) is the causative factor
behind the 2019 global coronavirus pandemic (COVID-19). The main protease, known as M …

[引用][C] COVID-19 therapeutics: Small-molecule drug development targeting SARS-CoV-2 main protease

T Kronenberger, SA Laufer… - Drug Discovery …, 2023 - ub01.uni-tuebingen.de
COVID-19 therapeutics: Small-molecule drug development targeting SARS-CoV-2 main protease
COVID-19 therapeutics: Small-molecule drug development targeting SARS-CoV-2 main protease …
[HTML] nih.gov

[HTML][HTML] COVID-19 therapeutics: Small-molecule drug development targeting SARS-CoV-2 main protease

T Kronenberger, SA Laufer, T Pillaiyar - Drug Discovery Today, 2023 - ncbi.nlm.nih.gov
The severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) is the causative factor
behind the 2019 global coronavirus pandemic (COVID-19). The main protease, known as M …

[引用][C] COVID-19 therapeutics: Small-molecule drug development targeting SARS-CoV-2 main protease

T Kronenberger, SA Laufer… - Drug Discovery …, 2023 - tobias-lib.ub.uni-tuebingen.de
COVID-19 therapeutics: Small-molecule drug development targeting SARS-CoV-2 main protease
COVID-19 therapeutics: Small-molecule drug development targeting SARS-CoV-2 main protease …

COVID-19 therapeutics: small-molecule drug development targeting SARS-CoV-2 main protease.

T Kronenberger, SA Laufer, T Pillaiyar - Drug Discovery Today, 2023 - europepmc.org
The severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) is the causative factor
behind the 2019 global coronavirus pandemic (COVID-19). The main protease, known as …